Viracta Therapeutics, Inc. reports

Company location: Cardiff, CA
Fiscal year end: 31 December

Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 76-100 of 861 matching filings.

Per page

25

Current page

4

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 09 Jun 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2023
Reporting date: 25 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2023
Reporting date: 25 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2023
Reporting date: 25 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-51531

144 filing

Filing date: 26 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-51531

10-Q

Filing date: 09 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 08 May 2023
Reporting date: 08 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K/A File 000-51531

8-K/A

Filing date: 05 May 2023
Reporting date: 27 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 02 May 2023
Reporting date: 27 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 000-51531

ARS

Filing date: 27 Apr 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 000-51531

DEFA14A

Filing date: 27 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-51531

DEF 14A

Filing date: 27 Apr 2023
Reporting date: 08 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Mar 2023
Reporting date: 16 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-270538

S-8

Filing date: 14 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-51531

10-K

Filing date: 14 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 13 Mar 2023
Reporting date: 13 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .